Jane Street Group LLC Has $1.25 Million Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Jane Street Group LLC lessened its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 45.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,118 shares of the company’s stock after selling 11,800 shares during the quarter. Jane Street Group LLC owned approximately 0.09% of U.S. Physical Therapy worth $1,252,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of USPH. Vanguard Group Inc. grew its position in shares of U.S. Physical Therapy by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 1,084,197 shares of the company’s stock valued at $96,179,000 after purchasing an additional 6,393 shares during the last quarter. Copeland Capital Management LLC grew its position in shares of U.S. Physical Therapy by 9.5% in the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock valued at $74,459,000 after purchasing an additional 72,715 shares during the last quarter. Southernsun Asset Management LLC grew its position in shares of U.S. Physical Therapy by 4.5% in the fourth quarter. Southernsun Asset Management LLC now owns 571,809 shares of the company’s stock valued at $50,725,000 after purchasing an additional 24,698 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of U.S. Physical Therapy by 1.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company’s stock valued at $37,818,000 after acquiring an additional 7,890 shares in the last quarter. Finally, Envestnet Asset Management Inc. grew its stake in shares of U.S. Physical Therapy by 20.1% in the fourth quarter. Envestnet Asset Management Inc. now owns 299,791 shares of the company’s stock valued at $26,594,000 after acquiring an additional 50,163 shares in the last quarter.

U.S. Physical Therapy Trading Down 0.5%

Shares of U.S. Physical Therapy stock opened at $79.33 on Wednesday. The company has a market capitalization of $1.21 billion, a price-to-earnings ratio of 84.39, a PEG ratio of 3.54 and a beta of 1.44. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $106.06. The firm’s 50-day moving average price is $71.94 and its two-hundred day moving average price is $83.53.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.02. The firm had revenue of $183.79 million for the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company’s revenue was up 18.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.51 EPS. On average, analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 23rd will be issued a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date of this dividend is Friday, May 23rd. U.S. Physical Therapy’s dividend payout ratio is presently 82.57%.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the firm’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. This trade represents a 19.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 2.00% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Barrington Research decreased their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. JMP Securities restated a “market outperform” rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. reduced their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 19th. William Blair reissued a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Finally, StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Thursday, May 8th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and an average price target of $109.00.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.